2025-10-14 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 September 2025 (Q3 2025). All figures are in USD unless…
